agilon health Inc AGL:NYSE

Earnings Announcement Next Earnings date is expected on 01/27/2022
Last Price$15.67NYSE Previous Close - Last Trade as of 7:00PM ET 1/26/22
NYSE 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.53 (4)
Ask (Size)$18.00 (1)
Day Low / HighN/A - N/A
Volume4.2 M
 

Read more news Recent News

--Deutsche Bank Adjusts Agilon Health's Price Target to $29 From $30, Maintains Buy Rating
8:00AM ET 1/25/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Wells Fargo Adjusts agilon Health Price Target to $31 From $44, Maintains Overweight Rating
11:43AM ET 1/06/2022 MT Newswires

Agilon Health (AGL) has an average rating of buy and price targets ranging from $30 to $44. (MT Newswires covers equity, commodity and economic research...

Insider Sell: Agilon Health
12:39PM ET 1/04/2022 MT Newswires

Theodore Halkias, Chief Business Officer, on December 30, 2021, sold 13,275 shares in Agilon Health (AGL) for $365,605. Following the Form 4 filing with...

Insider Sell: Agilon Health
5:14PM ET 12/30/2021 MT Newswires

Benjamin Shaker, Chief Markets Officer, on December 28, 2021, sold 18,740 shares in Agilon Health (AGL) for $499,890. Following the Form 4 filing with the...

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing01/10/20228-K

Company Highlights

Price Open$17.16
Previous Close$15.67
52 Week Range$14.93 - 44.83
Market Capitalization$6.2 B
Shares Outstanding393.7 M
SectorHealth Services
IndustryMedical/Nursing Services
Next Earnings Announcement01/27/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.92
Beta vs. S&P 500N/A
RevenueN/A
Net Profit Margin-21.39%
Return on Equity-72.74%

Analyst Ratings as of 10/19/2021

Buy
10
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset